(CIDRAP News) The Canadian Food Inspection Agency (CFIA) recently gave preliminary approval for field use of the world's first vaccine to reduce Escherichia coli O157:H7 in cattle and thereby help keep it out of food.
(CIDRAP News) – California scientists report that their analysis of the medical literature has yielded data on more than 600 molecular components of influenza A viruses that trigger immune responses, findings they hope will spur the search for vaccines offering protection against multiple flu strains.
For some 2 million Americans registered with 260 embassies or consulates abroad, the US government says its Web site (www.pandemicflu.gov) is designed to provide the latest information on avian and pandemic influenza.
(CIDRAP News) Federal officials have announced the launch of the first clinical trial of an H5N1 avian influenza vaccine made from a piece of the virus's DNA rather than from the whole virus, an approach that may facilitate faster vaccine production.
(CIDRAP News) – In an effort to expand the pool of antiviral drugs for influenza, the US government yesterday awarded a $102.6 million contract to BioCryst Pharmaceuticals Inc. of Birmingham, Ala., to develop peramivir, a new neuraminidase inhibitor.
(CIDRAP News) The US Department of Agriculture (USDA) yesterday proposed to reopen the US border to older Canadian cattle and beef for the first time since bovine spongiform encephalopathy (BSE) cropped up in Canada in 2003.
(CIDRAP News) Two Indonesians have been hospitalized in less than a week with H5N1 avian influenza infections, the countrys first in more than a month, according to news services.
Indonesias health ministry told Bloomberg News yesterday that a 14-year-old boy who tested positive for the H5N1 virus was being treated at Persahabatan Hospital in Jakarta after showing flulike symptoms on Jan 1.
(CIDRAP News) – The US Food and Drug Administration (FDA) has approved a refrigerated form of FluMist, the nasal-spray influenza vaccine, which should be more convenient for providers than the current formulation, MedImmune Inc. announced yesterday.
FluMist, a live attenuated vaccine first approved in 2003, is currently approved for use in healthy children and adults from ages 5 to 49 years.
(CIDRAP News) The World Health Organization (WHO) confirmed today that a 37-year-old man from China's Anhui province is recovering from H5N1 avian influenza, the country's first case in nearly 5 months, while hospital officials in Indonesia said one of two avian flu patients there died today.